Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InSysBio
Limassol, Cyprusinsysbio.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
InSysBio specializes in QSP and mechanistic modeling, supporting decision-making at all stages of drug development from preclinical to clinical; no proprietary programs with clinical results—impact is indirect via collaborations and client projects[1][4][5].
- Therapeutic areas
- Other
- Modalities
- Monoclonal antibodyAntibodySmall molecule
- Industry
- Drug Discovery Services
02
Partnerships
GenmabGSK (GlaxoSmithKline)discoveric bio alpha
Beyond the preview
Go deeper on InSysBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InSysBio.